Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

Blood. 2020 Oct 8;136(15):1786-1789. doi: 10.1182/blood.2019004685.

Abstract

Publisher's Note: There is a Blood Commentary on this article in this issue.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Postoperative Care*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use*
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors